ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide

N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide

N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide Structure
CAS No.
2028267-73-2
Chemical Name:
N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide
Synonyms
Tofacitinib N-Oxide;Tofacitinib-23;Tofacitib related impurities 8;Azilsartan medoxomil impurity334;N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide;1-Piperidinepropanenitrile, 4-methyl-3-(methyloxido-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R);1-Piperidinepropanenitrile, 4-methyl-3-(methyloxido-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R);N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide (Tofacitinib Impurity);3,3'-((3R,3'R,4R,4'R)-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis (methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxo propanenitrile);Tofacitinib impurity 17/Tofacitinib N-Oxide/N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide
CBNumber:
CB83363698
Molecular Formula:
C16H20N6O2
Molecular Weight:
328.37
MOL File:
2028267-73-2.mol
Modify Date:
2024/5/20 18:13:44

N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide Properties

pka -1.73±0.40(Predicted)

N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide Preparation Products And Raw materials

Raw materials

Preparation Products

3,3'-((3R,3'R,4R,4'R)-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis (methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxo propanenitrile) Tofacitinib-23 Tofacitinib impurity 17/Tofacitinib N-Oxide/N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide 1-Piperidinepropanenitrile, 4-methyl-3-(methyloxido-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R) 1-Piperidinepropanenitrile, 4-methyl-3-(methyloxido-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R) Azilsartan medoxomil impurity334 Tofacitib related impurities 8 N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide Tofacitinib N-Oxide N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide (Tofacitinib Impurity) 2028267-73-2 2036282-73-2